| Application no. and date | 15181155.1 (espacenet) (Federated) (European Patent Register), 20100625 | | Patent/reg. no. and date | DK/EP 2975051, 20210414 | | Publication date | 20160120 | | Priority no. and date | US 220687 P, 20090626 | | EP pub. no. and date |
EP 2975051 20160120 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | P76390DK01 | | Inventor | MACDONALD, Douglas, 260 West End Avenue Apt. 10C
New York, NY 10023, US,
DAVIS, Samuel, 332 West 88th Street Apt. B2
New York, NY 10024, US,
SMITH, Eric, 310 Lexington Avenue
Apt. 4E
New York, NY 10016, US,
OLSON, Kara Louise, 30 Prospect Street
White Plains, NY 10605, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , C07K 16/06 (2006.01) , C07K 16/24 (2006.01) , C07K 16/28 (2006.01) , C07K 16/46 (2006.01) | | Title | LET-AT-ISOLERE BISPECIFIKKE ANTISTOFFER MED NATIVT IMMUNOGLOBULINFORMAT | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
